NYSE:KVUE

Kenvue (KVUE) Stock Price, News & Analysis

$19.36
-0.22 (-1.12%)
(As of 04/23/2024 ET)
Today's Range
$19.27
$19.72
50-Day Range
$18.83
$21.46
52-Week Range
$17.82
$27.80
Volume
19.76 million shs
Average Volume
12.73 million shs
Market Capitalization
$37.07 billion
P/E Ratio
N/A
Dividend Yield
4.13%
Price Target
$24.85

Kenvue MarketRank™ Stock Analysis

Analyst Rating
Hold
2.38 Rating Score
Upside/​Downside
28.3% Upside
$24.85 Price Target
Short Interest
Healthy
2.23% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.73mentions of Kenvue in the last 14 days
Based on 14 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
9.57%
From $1.15 to $1.26 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.06 out of 5 stars

Consumer Staples Sector

35th out of 129 stocks

Toilet Preparations Industry

3rd out of 10 stocks

KVUE stock logo

About Kenvue Stock (NYSE:KVUE)

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

KVUE Stock Price History

KVUE Stock News Headlines

Johnson & Johnson is as Cheap as it’s Going to Get (KVUE)
Johnson & Johnson raised its dividend for the 62nd consecutive year and has the power to continue raising the annual payout indefinitely.
Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs? (KVUE)
Johnson & Johnson's proposed acquisition of Shockwave Medical may be the jolt that JNJ stock needs to break out of a year-long downtrend
Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars
Big Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver.
Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars
Big Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver.
Kenvue: Fairly Valued Spinout
Beyond The Numbers: 5 Analysts Discuss Kenvue Stock
5 Best Beauty Stocks To Invest In
How Is The Market Feeling About Kenvue?
55 March Dividend Kings: Buy 8; Watch 4
See More Headlines
Receive KVUE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kenvue and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/08/2024
Ex-Dividend for 2/28 Dividend
2/13/2024
Dividend Payable
2/28/2024
Today
4/24/2024
Next Earnings (Confirmed)
5/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Toilet preparations
Sub-Industry
N/A
Fax
N/A
Employees
22,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$24.85
High Stock Price Target
$30.00
Low Stock Price Target
$18.00
Potential Upside/Downside
+28.3%
Consensus Rating
Hold
Rating Score (0-4)
2.38
Research Coverage
16 Analysts

Profitability

Net Income
$1.66 billion
Pretax Margin
14.18%

Debt

Sales & Book Value

Annual Sales
$15.44 billion
Cash Flow
$1.55 per share
Book Value
$5.85 per share

Miscellaneous

Outstanding Shares
1,914,648,000
Free Float
N/A
Market Cap
$37.07 billion
Optionable
Optionable
Beta
N/A
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Thibaut Mongon (Age 53)
    CEO & Director
    Comp: $4.79M
  • Mr. Paul Ruh (Age 56)
    Chief Financial Officer
    Comp: $2.33M
  • Ms. Meredith Stevens (Age 61)
    Chief Operations Officer
    Comp: $1.84M
  • Mr. Carlton Lawson (Age 55)
    Group President of EMEA & Latin America
    Comp: $2.28M
  • Ms. Ellie Bing Xie (Age 54)
    Group President of Asia Pacific
    Comp: $2.94M
  • Ms. Heather R. Howlett (Age 46)
    Chief Accounting Officer
  • Mr. Bernardo Tavares (Age 56)
    Chief Data & Technology Officer
  • Dr. Caroline Tillett (Age 52)
    Chief Scientific Officer
  • Ms. Tina Romani
    Head of Investor Relations
  • Mr. Matthew Orlando (Age 47)
    General Counsel

KVUE Stock Analysis - Frequently Asked Questions

Should I buy or sell Kenvue stock right now?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Kenvue in the last year. There are currently 1 sell rating, 8 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" KVUE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KVUE, but not buy additional shares or sell existing shares.
View KVUE analyst ratings
or view top-rated stocks.

What is Kenvue's stock price target for 2024?

16 Wall Street research analysts have issued 1 year target prices for Kenvue's stock. Their KVUE share price targets range from $18.00 to $30.00. On average, they expect the company's stock price to reach $24.85 in the next twelve months. This suggests a possible upside of 28.3% from the stock's current price.
View analysts price targets for KVUE
or view top-rated stocks among Wall Street analysts.

How have KVUE shares performed in 2024?

Kenvue's stock was trading at $21.53 at the beginning of the year. Since then, KVUE stock has decreased by 10.1% and is now trading at $19.36.
View the best growth stocks for 2024 here
.

Are investors shorting Kenvue?

Kenvue saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 34,600,000 shares, an increase of 26.0% from the March 15th total of 27,450,000 shares. Based on an average trading volume of 16,620,000 shares, the days-to-cover ratio is presently 2.1 days. Approximately 2.2% of the shares of the company are sold short.
View Kenvue's Short Interest
.

When is Kenvue's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our KVUE earnings forecast
.

How can I listen to Kenvue's earnings call?

Kenvue will be holding an earnings conference call on Tuesday, May 7th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Kenvue's earnings last quarter?

Kenvue Inc. (NYSE:KVUE) posted its earnings results on Thursday, February, 8th. The company reported $0.31 EPS for the quarter, topping analysts' consensus estimates of $0.28 by $0.03. The firm earned $3.67 billion during the quarter, compared to analysts' expectations of $3.78 billion. Kenvue had a net margin of 9.87% and a trailing twelve-month return on equity of 15.62%. The business's revenue was down 2.7% on a year-over-year basis.

How often does Kenvue pay dividends? What is the dividend yield for Kenvue?

Kenvue declared a quarterly dividend on Thursday, January 25th. Stockholders of record on Wednesday, February 14th will be paid a dividend of $0.20 per share on Wednesday, February 28th. This represents a $0.80 annualized dividend and a yield of 4.13%. The ex-dividend date is Tuesday, February 13th.
Read our dividend analysis for KVUE
.

Is Kenvue a good dividend stock?

Kenvue (NYSE:KVUE) pays an annual dividend of $0.80 per share and currently has a dividend yield of 4.09%. KVUE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for KVUE.

What guidance has Kenvue issued on next quarter's earnings?

Kenvue updated its FY 2024 earnings guidance on Thursday, February, 8th. The company provided earnings per share guidance of 1.100-1.200 for the period, compared to the consensus estimate of 1.260. The company issued revenue guidance of $15.6 billion-$15.9 billion, compared to the consensus revenue estimate of $15.9 billion.

When did Kenvue IPO?

Kenvue (KVUE) raised $3.3 billion in an IPO on Thursday, May 4th 2023. The company issued 151,200,000 shares at $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan, BofA Securities, Citigroup, Deutsche Bank Securities, BNP PARIBAS, HSBC, RBC Capital Markets and UBS Investment Bank acted as the underwriters for the IPO.

Who are Kenvue's major shareholders?

Kenvue's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Raymond James & Associates (0.27%), Sumitomo Mitsui Trust Holdings Inc. (0.20%), MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH (0.13%), Stonegate Investment Group LLC (0.12%), Renaissance Capital LLC (0.05%) and Gradient Investments LLC (0.04%).
View institutional ownership trends
.

How do I buy shares of Kenvue?

Shares of KVUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:KVUE) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners